In patients with severe COVID-19, we show innate and adaptive immune dysfunction, including loss of immunesuppression by blood myeloid cells and the replacement of lung memory CD8+ T cells by naive T cells, suggesting a state of “immune silence” that correlates with a severe clinical manifestation and fatal outcome. The gene discussed is CD8A; the disease is COVID-19.